JTG MEDICAL LTD

Executive Summary

JTG Medical Ltd is a newly established micro-entity in specialist medical practice with a sound initial balance sheet showing positive working capital and no overdue filings. While credit approval is recommended given current financial health and owner control, careful monitoring of trading performance and liquidity is advised due to limited operating history. The company’s ability to generate sustainable cash flow will be key to ongoing creditworthiness.

JTG MEDICAL LTD - Analysis Report

Company Number: 15054002

Analysis Date: 2025-07-20 15:19 UTC

1. Credit Opinion: APPROVE with monitoring.
   JTG Medical Ltd is a newly incorporated micro-entity providing specialist medical practice services. The company shows a positive net current asset position and no overdue filings, indicating initial sound financial discipline. However, as a start-up with limited trading history and a single director who is also the sole shareholder, caution is warranted. Approval is recommended with conditions to monitor trading performance and liquidity over the next 12 months.

2. Financial Strength:
   The balance sheet as of 31 August 2024 shows current assets of £24,102 against current liabilities of £11,572, yielding net current assets (working capital) of £12,530. There are no fixed assets or reported long-term liabilities, and shareholders’ funds equal £12,530, reflecting the initial equity injection. The company has no accumulated reserves or retained earnings yet, consistent with its recent incorporation and early trading stage.

3. Cash Flow Assessment:
   Current assets mainly comprise cash or equivalents and/or receivables, sufficient to cover short-term liabilities by a 2:1 ratio, which is healthy for a start-up. The positive working capital suggests the company can meet its immediate obligations. However, with only one employee and presumably minimal revenue to date, ongoing cash flow generation is untested. Close attention to cash inflows from operations and timely creditor payments is necessary.

4. Monitoring Points:

• Revenue growth and profitability trends in subsequent accounts to assess trading viability.
• Maintenance of positive working capital and liquidity ratios.
• Any increase in liabilities or commitments that may strain cash flow.
• Director's ability to manage the business alongside clinical commitments.
• Timely submission of statutory filings to avoid compliance risk.